What is Organon & Co.'s Market Cap?

Organon & Co.'s Market Cap is $3.6B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Enterprise Value?

Organon & Co.'s Enterprise Value is $11.0B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Trailing P/E?

Organon & Co.'s Trailing P/E is 17.3×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Price / Sales?

Organon & Co.'s Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s EV / Revenue?

Organon & Co.'s EV / Revenue is 1.8×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s EV / EBITDA?

Organon & Co.'s EV / EBITDA is 8.3×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Revenue (TTM)?

Organon & Co.'s Revenue (TTM) is $6.1B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Net Income (TTM)?

Organon & Co.'s Net Income (TTM) is $209.0M, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s EBITDA?

Organon & Co.'s EBITDA is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Diluted EPS (TTM)?

Organon & Co.'s Diluted EPS (TTM) is 0.80, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Organon & Co.

XNYS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZQRGW42

13.75▲ 0.00 (0.00%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 13.75
Day's Range: 13.74 – 13.76
52-Week Range: 5.69 – 13.83
Volume: 1.1M
Avg Volume: 2.2M

Share Statistics

Shares Outstanding
Employees: 10.0K
Exchange: XNYS
Listed: 2021-05-14

Share count as of July 24, 2026

Organon & Co. (OGN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Organon & Co. (OGN)

What is Organon & Co.'s Market Cap?: Organon & Co.'s Market Cap is $3.6B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Enterprise Value?: Organon & Co.'s Enterprise Value is $11.0B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Trailing P/E?: Organon & Co.'s Trailing P/E is 17.3×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Price / Sales?: Organon & Co.'s Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s EV / Revenue?: Organon & Co.'s EV / Revenue is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s EV / EBITDA?: Organon & Co.'s EV / EBITDA is 8.3×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Revenue (TTM)?: Organon & Co.'s Revenue (TTM) is $6.1B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Net Income (TTM)?: Organon & Co.'s Net Income (TTM) is $209.0M, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s EBITDA?: Organon & Co.'s EBITDA is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Diluted EPS (TTM)?: Organon & Co.'s Diluted EPS (TTM) is 0.80, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · OGNAs-filed SEC (XBRL) data